Nutritional factors in inflammatory bowel disease

Area of Science:

• Gastroenterology
• Immunology
• Nutritional Science

Background:

• Dietary antigens stimulate the mucosal immune system, prompting research into nutritional therapy for Inflammatory Bowel Disease (IBD).
• Active Crohn's Disease (CD) patients show response to bowel rest with total enteral nutrition (TEN) or total parenteral nutrition (TPN).

Purpose of the Study:

• To evaluate the efficacy of nutritional interventions in managing Inflammatory Bowel Disease (IBD), including Crohn's disease (CD) and Ulcerative Colitis (UC).
• To explore the role of specific nutrients and dietary components in IBD treatment.

Main Methods:

• Review of studies on bowel rest, total enteral nutrition (TEN), total parenteral nutrition (TPN), and specific diets (elemental, polymeric) for CD and UC.
• Investigation into the effects of fish oil (n-3-PUFA), short-chain fatty acids, and probiotics in IBD management.

Main Results:

• Bowel rest and TPN induce short-term remission in active CD, comparable to corticosteroids but with limited duration.
• Enteral nutrition is less effective than corticosteroids for active CD; polymeric diets show similar efficacy to elemental diets.
• Nutritional therapies have shown limited success in Ulcerative Colitis (UC).
• Fish oil demonstrates some benefit in CD treatment by inhibiting proinflammatory cytokines.
• Short-chain fatty acids and probiotics show promise for specific conditions like diversion colitis, distal UC, and pouchitis.

Conclusions:

• Nutritional therapy, particularly bowel rest with TPN, offers a short-term remission induction strategy for active CD.
• Conventional treatments remain superior for long-term CD management, while UC response to nutritional therapy is poor.
• Emerging therapies like fish oil, short-chain fatty acids, and probiotics present potential adjunctive or specific treatment options for IBD subtypes.